Clinical trial
An Open, Randomized, Parallel Control, Multiple-center Phase II Trial of Two Different Dosages of Irinotecan Combined With Cisplatin Scheme in Extensive Disease-Small Cell Lung Cancer
NCT01977235 is registered in ClinicalTrials.gov with Third Military Medical University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- An Open, Randomized, Parallel Control, Multiple-center Phase II Trial of Two Different Dosages of Irinotecan Combined With Cisplatin Scheme in Extensive Disease-Small Cell Lung Cancer
- Lead sponsor
- Third Military Medical University
- Phase
- Phase 2
- Overall status
- Unknown status
- Start date
- September 30, 2013
- Completion date
- September 30, 2017
- Enrollment
- 110 (estimated)
- Sites
- 3
Conditions
As the registry lists them; a condition with its own page is linked.